<div>Two Baby Sisters, One Medicine Worth Crores. You Can Save Their Lives


</div>


<div><br />


</div><img class="text-editor_textEditorImage__43_GE" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/95890673_1761197328893566_r." width="100%" />


<div><br />


</div>


<div>In a split second, both my daughters are fighting for their lives against the cruel disease of Spinal Muscular Atrophy, and need life-saving medical treatment of Rs.18 crores.”


</div>


<div>am Rekha, the mother of two beautiful baby girls, Kaashvi, who is 2.8 years old, and Arohvi, who is only 2 months old. They are the biggest blessing of my life, and giving birth to them has been my greatest achievement. They are my world, my everything. 


</div>


<div>But now my world has shattered. 


</div>


<div><br />


</div>


<div>Kaashvi and Arohvi have been diagnosed with a rare, progressive, and life-threatening genetic disorder—spinal muscular atrophy. The disease threatens to steal their lives, and only a one-time gene therapy called Zolgensma can save them. 


</div>


<div><br />


</div>


<div><br />


</div><img class="text-editor_textEditorImage__43_GE" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/95890673_1761197543535485_r." width="100%" />


<div><br />


</div>


<div>SMA is a disease that, over time, attacks the muscles, making it difficult for the child to perform any movement. As it progresses, it even makes breathing and swallowing difficult, almost impossible. It needs early detection and treatment, without which my daughters’ lives are in danger. SMA is of two types


</div>


<div>Kaashvi, my elder daughter, is diagnosed with SMA Type 2, which could lead to significant disability and loss of motor function over time.


</div>


<div>Arohvi, my younger daughter, is diagnosed with SMA Type 1, which is more severe and could be fatal if untreated in early infancy.


</div>


<div>To save the lives of my babies, they will need Zolgensma, which can halt the progression of SMA and give them a chance at life. Tragically, this life-saving drug costs Rs. 16 crores per child.


</div>


<div><br />


</div><img class="text-editor_textEditorImage__43_GE" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/95890673_1761197648463517_r." width="100%" />


<div><br />


</div>


<div><br />


</div>


<div>As parents, nothing matters to us more than the lives of our children. Although we are a middle-class family, we are ready to do whatever it takes, sacrifice all we have to save their lives. Yet, even after doing all we can, this amount eludes us, and we are nowhere close to this amount. We’ve been in constant touch with Novartis, the manufacturer of Zolgensma, who, understanding our plight, has allowed us to have an EMI plan to pay for the drug. Accordingly, we need to immediately pay Rs. 9 Crores for each of our daughters, and the rest in phases.


</div>


<div>Words cannot describe the pain and mental turmoil we’ve been undergoing to arrange for this fund. We’ve been reaching out to organizations, friends, strangers, and anyone willing to listen, but this is an unimaginably large sum of money to arrange for in such a short time. In this desperate situation, we put our hopes in you and reach out to you through this fundraiser, seeking your help. Only your financial assistance can make it possible to save my daughters’ lives. 


</div>


<div>Please donate generously and offer life to my two daughters. Share this campaign with friends, family, and on all social media platforms, urging them to donate any amount, because it will save not one but two lives. Your help will be transformative. 


</div>


<div><br />


</div><img class="text-editor_textEditorImage__43_GE" alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/95890673_1761197761646039_r." width="100%" />


<div>I appreciate your kindness and generosity; may you be richly blessed for it. Thank you for your timely and invaluable support. 


</div>

Help Kaashvi and Arohvi Get Life-Saving Treatment

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Voer je donatie voor Help Kaashvi and Arohvi Get Life-Saving Treatment